Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KPTI US Equity

Karyopharm Therapeutics Inc.Health Care · Pharmaceutical Preparations · CIK 1503802 · FY ends Dec 31
$2.00
+0.07 (+3.63%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Commodore Capital LPsec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Adage Capital Management, L.P.sec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by GOLDMAN SACHS GROUP INCsec.gov ↗
2026-07-318-K 8.01Other eventssec.gov ↗
2026-07-2813GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-178-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-17

Every row is a filed document, checked against its EDGAR index.